Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used for the treatment of severe asthma.
Those who have it are at an increased risk of developing osteoporosis or fracture and may wish to consider treatment options as well. When used to treat osteopenia, the doses of some of these ...